Pancreatic Cancer Research

ResearcherIndiana University HealthActive in the last 2 years

Ashiq Masood

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1848-1178; OpenAlex author ID A5007845498. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
65
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 3 papers

Papers 8

  1. Pancreatic Adenocarcinoma, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. Co-author DOI 10.6004/jnccn.2026.0046↗
  2. ProAgio, a Novel Integrin αvβ3 Targeted Cytotoxin, Suppresses Tumor Growth and Reprograms the PDAC Microenvironment Co-author DOI 10.64898/2026.01.15.699725↗
  3. Conserved Metastatic Cell States and Spatial Immune Microenvironment Remodeling Define Pancreatic Cancer Liver Metastases Co-author DOI 10.64898/2026.05.27.728281↗
  4. Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: A sing… Co-author DOI 10.1016/j.canlet.2025.217809↗
  5. Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine. Co-author DOI 10.1016/j.xcrm.2024.101881↗
  6. High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival. Co-author DOI 10.1038/s41698-023-00455-z↗
  7. Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer. Last author DOI 10.3390/ijms21207651↗
  8. Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy. Co-author DOI 10.3390/cancers3021527↗

Closest collaborators

The 25 strongest of 65 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sujith Sarvesh · 3 shared papers, 2025–2026 · strength 0.73
  2. Dhana Sekhar Reddy Bandi · 3 shared papers, 2025–2026 · strength 0.73
  3. Ganji Purnachandra Nagaraju · 3 shared papers, 2025–2026 · strength 0.73
  4. Mehmet Akce · 3 shared papers, 2025–2026 · strength 0.73
  5. Bassel F. El‐Rayes · 3 shared papers, 2025–2026 · strength 0.73
  6. Karina Jin Yoon · 2 shared papers, 2025–2026 · strength 0.46
  7. Jeremy B. Foote · 2 shared papers, 2025–2026 · strength 0.46
  8. Julienne L. Carstens · 2 shared papers, 2025–2026 · strength 0.45
  9. Harrison Kim · 1 shared paper, 2026 · strength 0.27
  10. Midhun Malla · 1 shared paper, 2026 · strength 0.27
  11. Zhi-Ren Liu · 1 shared paper, 2026 · strength 0.27
  12. Ayushi Mandloi · 1 shared paper, 2026 · strength 0.26
  13. Upender Manne Manne · 1 shared paper, 2025 · strength 0.19
  14. Yuvasri Golivi · 1 shared paper, 2025 · strength 0.19
  15. Cameron J. Herting · 1 shared paper, 2025 · strength 0.19
  16. Olatunji Boladale Alese · 1 shared paper, 2025 · strength 0.19
  17. Manoj Bhasin · 1 shared paper, 2025 · strength 0.19
  18. Gregory B. Lesinski · 1 shared paper, 2025 · strength 0.19
  19. Timothy R. Donahue · 1 shared paper, 2026 · strength 0.19
  20. Olca Baştürk · 1 shared paper, 2026 · strength 0.19
  21. George A. Poultsides · 1 shared paper, 2026 · strength 0.19
  22. Andrew H. Ko · 1 shared paper, 2026 · strength 0.19
  23. Charles M. Vollmer · 1 shared paper, 2026 · strength 0.19
  24. Marco Del Chiaro · 1 shared paper, 2026 · strength 0.19
  25. Brian G. Czito · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.